Benefits of combination pharmacotherapy for HFrEF
- PMID: 32528186
- DOI: 10.1038/s41569-020-0405-9
Benefits of combination pharmacotherapy for HFrEF
Comment on
-
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.Lancet. 2020 Jul 11;396(10244):121-128. doi: 10.1016/S0140-6736(20)30748-0. Epub 2020 May 21. Lancet. 2020. PMID: 32446323 Clinical Trial.
References
Original article
-
- Vaduganathan, M. et al. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Lancet https://doi.org/10.1016/S0140-6736(20)30748-0 (2020) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical